dc.contributor.author |
Stefan, Norbert |
|
dc.date.accessioned |
2025-01-07T08:08:29Z |
|
dc.date.available |
2025-01-07T08:08:29Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
1745-6215 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/159811 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
London : Bmc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1186/s13063-024-08208-4 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20241001000000_01164 |
|
utue.personen.roh |
Stefan, Norbert |
|
utue.personen.roh |
Hartleb, Marek |
|
utue.personen.roh |
Popovic, Branko |
|
utue.personen.roh |
Varona, Rafael |
|
dcterms.isPartOf.ZSTitelID |
Trials |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 374 |
de_DE |
dcterms.isPartOf.ZS-Volume |
25 (1) |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |